These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 9032231)
1. E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis. Nip J; Strom DK; Fee BE; Zambetti G; Cleveland JL; Hiebert SW Mol Cell Biol; 1997 Mar; 17(3):1049-56. PubMed ID: 9032231 [TBL] [Abstract][Full Text] [Related]
2. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression. Nip J; Hiebert SW Cell Biochem Biophys; 2000; 33(2):199-207. PubMed ID: 11325040 [TBL] [Abstract][Full Text] [Related]
3. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex. Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981 [TBL] [Abstract][Full Text] [Related]
4. Additive effect of adenovirus-mediated E2F-1 gene transfer and topoisomerase II inhibitors on apoptosis in human osteosarcoma cells. Yang HL; Dong YB; Elliott MJ; Wong SL; McMasters KM Cancer Gene Ther; 2001 Apr; 8(4):241-51. PubMed ID: 11393276 [TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors. Dong YB; Yang HL; Elliott MJ; McMasters KM Cancer Res; 2002 Mar; 62(6):1776-83. PubMed ID: 11912154 [TBL] [Abstract][Full Text] [Related]
6. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin. Meng RD; Phillips P; El-Deiry WS Int J Oncol; 1999 Jan; 14(1):5-14. PubMed ID: 9863003 [TBL] [Abstract][Full Text] [Related]
8. E2F-1 gene therapy induces apoptosis and increases chemosensitivity in human pancreatic carcinoma cells. Elliott MJ; Farmer MR; Atienza C; Stilwell A; Dong YB; Yang HL; Wong SL; McMasters KM Tumour Biol; 2002; 23(2):76-86. PubMed ID: 12065845 [TBL] [Abstract][Full Text] [Related]
9. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1. Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823 [TBL] [Abstract][Full Text] [Related]
10. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells. Yang HL; Dong YB; Elliott MJ; Liu TJ; McMasters KM Clin Cancer Res; 2000 Apr; 6(4):1579-89. PubMed ID: 10778992 [TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated E2F-1 gene transfer inhibits MDM2 expression and efficiently induces apoptosis in MDM2-overexpressing tumor cells. Yang HL; Dong YB; Elliott MJ; Liu TJ; Atienza C; Stilwell A; McMasters KM Clin Cancer Res; 1999 Aug; 5(8):2242-50. PubMed ID: 10473112 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of cyclin A kinase activity in E2F-1 chemogene therapy of colon cancer. Elliott MJ; Baker JD; Dong YB; Yang HL; Gleason JF; McMasters KM Tumour Biol; 2002; 23(6):324-36. PubMed ID: 12677090 [TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors. Atienza C; Elliott MJ; Dong YB; Yang HL; Stilwell A; Liu TJ; McMasters KM Int J Mol Med; 2000 Jul; 6(1):55-63. PubMed ID: 10851267 [TBL] [Abstract][Full Text] [Related]
14. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology]. Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576 [TBL] [Abstract][Full Text] [Related]
15. p53 and E2F-1 cooperate to mediate apoptosis. Wu X; Levine AJ Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3602-6. PubMed ID: 8170954 [TBL] [Abstract][Full Text] [Related]
16. Flavopiridol-induced apoptosis during S phase requires E2F-1 and inhibition of cyclin A-dependent kinase activity. Jiang J; Matranga CB; Cai D; Latham VM; Zhang X; Lowell AM; Martelli F; Shapiro GI Cancer Res; 2003 Nov; 63(21):7410-22. PubMed ID: 14612540 [TBL] [Abstract][Full Text] [Related]
17. Functional interplay between p53 and E2F through co-activator p300. Lee CW; Sørensen TS; Shikama N; La Thangue NB Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736 [TBL] [Abstract][Full Text] [Related]
18. Small contribution of G1 checkpoint control manipulation to modulation of p53-mediated apoptosis. Canman CE; Kastan MB Oncogene; 1998 Feb; 16(8):957-66. PubMed ID: 9519869 [TBL] [Abstract][Full Text] [Related]
19. Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53. Blattner C; Sparks A; Lane D Mol Cell Biol; 1999 May; 19(5):3704-13. PubMed ID: 10207094 [TBL] [Abstract][Full Text] [Related]
20. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck. Frank DK; Liu TJ; Frederick MJ; Clayman GL Clin Cancer Res; 1998 Sep; 4(9):2265-72. PubMed ID: 9748148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]